For the treatment of irritable bowel syndrome characterized by pain, bloating in the abdomen and irregular bowel function
Colilen IBS is a pioneering product for the treatment of irritable bowel syndrome, a disorder manifested by varying intensity through multiple symptoms, varying from person to person.
INDICATIONS
Colilen IBS is indicated for the treatment of irritable bowel syndrome, characterized by pain, bloating, dilation and abdominal discomfort, with or without differentiation in the form of stools and irregular bowel function (constipation, diarrhea or alternation of the two).
Due to its protective mechanism, Colilen IBS gradually reduces intestinal disturbances and, depending on the severity of the disorder, it is recommended to extend the treatment for 2 to 6 weeks and to repeat it in case of recurrence with the onset of the first symptoms.
HOW ACT
Colilen IBS capsules work thanks to the patented molecular complex (IT No 102012902020829) ActiMucin, consisting of resins, polysaccharides and polyphenols. ActiMucin, through a mechanical-physical mechanism, interacts with the surface of the intestinal mucosa forming a protective membrane that protects the mucosa from contact with irritants.
WARNINGS
The product is suitable from the age of 8 years. It is contraindicated during pregnancy and lactation. Do not take in case of hypersensitivity or single allergy to one or more ingredients. Store at ambient temperature, away from sources of heat and protected from light. Keep out of reach of children. The expiry date refers to a product intact and well preserved.
Barcode: 8032472014713
